Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

aTYR PHARMA (ATYR) Preferred Shares (2019)

aTYR PHARMA (ATYR) has disclosed Preferred Shares for 1 consecutive years, with $2000.0 as the latest value for Q4 2019.

  • For the quarter ending Q4 2019, Preferred Shares changed N/A year-over-year to $2000.0, compared with a TTM value of $2000.0 through Dec 2019, changed N/A, and an annual FY2019 reading of $2000.0, changed N/A over the prior year.
  • Preferred Shares was $2000.0 for Q4 2019 at aTYR PHARMA, roughly flat from $2000.0 in the prior quarter.
  • Across five years, Preferred Shares topped out at $2000.0 in Q1 2019 and bottomed at $2000.0 in Q1 2019.